Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Virogin Biotech
company
About
Virogin Biotech is an antineoplastic drug developer.
- 101 - 250
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $7M
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment.By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
6
$194M
Virogin Biotech has raised a total of
$194M
in funding over 2 rounds. Their latest funding was raised on
Sep 24, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 24, 2021 | Series D | $120M | 1 |
|
— | Detail |
| Sep 28, 2020 | Series C | $62M | 2 | — | — | Detail |
| Jun 7, 2020 | Series B | — | 1 | — | — | Detail |
| Feb 28, 2017 | Series A | $5M | 2 | — | — | Detail |
| Mar 21, 2016 | Series A | $7M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
6
Virogin Biotech is funded by 6 investors.
China Life Healthcare Fund
and Gimpo Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series D |
|
|
Yes | Seed |
|
|
— | Series C |
Peking University Mingde Fund
|
— | Series C |
|
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
